News
Bloomberg on MSN2h
Novartis CEO on Psoriasis Drug, China Growth, Tariffs, M&ANovartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.
In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...
Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...
Novartis (NVS) raised its full-year profit outlook thanks to strong demand for some of its key drugs. Novartis CEO Vas ...
President Donald Trump says that he was likely to impose tariffs on pharmaceuticals as soon as the end of this month.
Anticipating potential tariffs on South Korean goods, particularly cosmetics, U.S. consumers are stocking up on K-beauty ...
Oil prices rose $1 on Thursday after drones struck Iraqi Kurdistan oil fields for a fourth day, pointing to continued risk in ...
Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...
By Miranda Murray and Patricia Weiss BERLIN (Reuters) -Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key drugs such as Kisqali, ...
President Trump on Wednesday said he would be sending letters to over 150 countries as he plans a barrage of duties to take ...
By Noreen Marcus, FloridaBulldog.org - Trump’s tariff assault on drug affordability stings a Vero Beach cancer patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results